Check out our latest 3HP Options Trial paper. Describes findings from interviews with patients and healthcare workers, addressing barriers to acceptance/completion of 3HP TB preventive therapy among people living with HIV in Uganda. https://t.co/fB93JjRGI7
511 followers
144 followers
RT @ImplementSci: Acceptance and completion of rifapentine-based TB preventive therapy among people living with HIV in Uganda — patient and…
1,235 followers
Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives https://t.co/pTRj8FMn1o
8,858 followers
Acceptance and completion of rifapentine-based TB preventive therapy among people living with HIV in Uganda — patient and health worker perspectives #ImpSciComms #impsci https://t.co/gNUEHK6D4W